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Histamine elevates the intracellular cyclic AMP levels in cultured embryonic hick retinal pigment 
epithelium. The half-maximal ctivity is 6 x 10m6 M. The effect of histamine ismediated by Hz receptors, 
i.e., inhibited by the Hz antagonist cimetidine and not affected by the HI antagonists diphenhydramine 
and pyrilamine. The inhibition constant (Kr) of cimetidine is1.3 x lo-* M. Thus, the present system offers 
the opportunity of studying the nature of coupling between histamine receptors and adenylate cyclase 
under controlled conditions in a homogeneous cell type. 
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1. INTRODUCTION 
The nature of coupling between cellular 
histamine receptors and the cyclic AMP system is 
not as well understood as that for most other hor- 
monal and neuromodulatory receptors, e.g., 
catecholamine and glucagon receptors. Partly, this 
is due to the unavailability of cultured cell lines 
and easily isolatable pure cell types responsive to 
histamine [ 11. 
The retinal pigment epithelium (RPE) is a single 
layer of specialized neuroepithelial cells juxtaposed 
between the choroid and the neurosensory retina 
of the eye. RPE from chick embryo of 7-10 days 
of development can easily be isolated free from 
contaminating cell types and grown in culture. 
This culture system has been studied for some time 
and is quite well defined [2]. These cultured cells 
retain many of the differentiated characteristics 
seen in cell in vivo [3,4] and are capable of perfor- 
ming several specialized functions including pro- 
ducing melanin, and phagocytizing isolated bovine 
rod outer segment [5]. 
of potential importance in maintaining the blood- 
brain barrier. Since the RPE is the actual site of the 
blood-retina barrier [7,8], the histamine response 
in these cells may be of particular interest. Our 
preliminary work has shown that several hormones 
and neurotransmitters, including histamine, 
elevated the intracellular cyclic AMP concentra- 
tion of cultured RPE 191. Here, we have 
characterized the histamine effect on the in- 
tracellular cyclic AMP concentration in cultured 
chick embryonic RPE and found that the 
histamine effect is mediated by the HZ receptor; 
i.e., inhibited by HZ antagonist and not affected by 
HI antagonists. 
2. MATERIALS AND METHODS 
2.1. Cell cultures 
Histamine has been postulated to be involved in 
the control of capillary permeability [6] and thus 
Sheets of RPE cells were dissected cleanly from 
eyes of g-day old chicken embryo. After incuba- 
tion of RPE sheets in an enzyme solution contain- 
ing 0.6 units/ml collagenase, 0.01% trypsin, 0.2% 
chicken serum and 0.4 mM EDTA in Dulbecco’s 
phosphate-buffered saline (pH 7.4) for 5 min at 
37”C, cells were seeded at 2 x 104 cells/ml in 
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35 mm Costar culture dishes. Monolayer cultures 
were maintained in 2 ml of Eagle’s minimal essen- 
tial medium (with Earl’s salts) containing 5% heat- 
inactivated fetal bovine serum with 50 units/ml 
penicillin and 50 pg/ml streptomycin. The cultures 
were incubated at 37°C under humidified 5% 
CO2/95% air for 3-4 weeks before use. These 
cultures retained many of the differentiated 
characteristics, i.e., pigmentation and phagocytic 
capacity, seen in cells in vivo [3-51. When the pro- 
cedure of isolating cells was carried out carefully, 
no contaminating cell types were detected under 
the light microscope. 
2.2. Intracellular cyclic AMP determination 
The procedures used were very similar to those 
reported earlier [lo]. The culture medium was 
changed to 2 ml serum-free Eagle’s minimum 
essential medium containing 20 mM Hepes buffer 
(pH 7.2) and 20 PM 4-(3-butoxy-4-methoxy- 
benzyl)-2-imidazolidinone (Ro20-1724), a phos- 
phodiesterase inhibitor. After 40 min at 25”C, 
histamine solution (20 ~1) was added to the culture. 
The incubation was continued for an additional 
3 min, before removing the incubation medium 
and extracting intracellular cyclic AMP with 2 ml 
of boiling water. The reaction period was kept at 
3 min to allow linear production of intracellular 
cyclic AMP without leakage into the medium. 
When applicable, histamine antagonists were add- 
ed to the incubation medium 12 min before ap- 
plication of histamine. Each dish was scraped with 
a rubber policeman and its content was boiled for 
15 min. The concentration of cyclic AMP in the 
extract was determined by radioimmunoassay us- 
ing ‘251-cyclic AMP and cyclic AMP antiserum 
complex. 
2.3. Protein quantitation 
The protein concentration was determined as in 
1111. 
2.4. Materials 
Dulbecco’s phosphate-buffered saline and ingre- 
dients used in the culture media were obtained 
from Grand Island Biological Co. (Grand Island, 
NY). ‘251-cyclic AMP and cyclic AMP antiserum 
complex were from New England Nuclear (Boston, 
MA). Histamine 2HC1, cimetidine, diphenhydra- 
mine HCl, pyrilamine-maleate were from Sigma 
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(St Louis, MO). Ro-20-1724 was a kind gift from 
Hoffman LaRoche Inc. 
3. RESULTS 
The effect of increasing concentrations of 
histamine on the intracellular cyclic AMP concen- 
tration of cultured RPE cells is shown in fig. 1. The 
concentration required for a half-maximal effect is 
about 5.8 x 10m6 M, while the maximal effect is 
observed at about 10v4 M. The maximal cyclic 
AMP concentration achieved by histamine is about 
40-fold over the basal level of 9.3 pmol/mg pro- 
tein. Also shown in fig.1 is that cimetidine, a 
specific Hz-antagonist, at 3 x 10m6 M, completely 
abolishes the effect of histamine. 
. 
Several histamine antagonists were tested for 
their effects on the histamine-elevated intracellular 
cyclic AMP levels. As is shown in fig.2, the 
Hi-antagonists, diphenhydramine and pyrilamine, 
have no effect on the intracellular cyclic AMP 
elevated by 1 x 10e6 M histamine. On the other 
hand, cimetidine, an Hz-antagonist very effectively 
inhibits the histamine effect in a dose-dependent 
manner (fig.2). The half-maximal inhibition (Z&I) 
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Fig. 1. Concentration dependency of the histamine effect 
on the intracellular cyclic AMP concentration i RPE 
cells. RPE cells from 9-day old embryos were grown for 
4 weeks before testing. In the absence of histamine, the 
basal cyclic AMP levels averaged 9.0 (0) and 9.8 (0) 
pmol/mg RPE protein, as determined from 3 and 2 
culture dishes, respectively. In the presence of 3 x 
10m6 M cimetidine (B), histamine had no effect on the 
cyclic AMP level. The basal cyclic AMP level was not 
affected by the presence of 3 x 10m6 M cimetidine. Each 
point represents one (o,o) and two (m) culture dishes, 
each with duplicate radioimmunoassay for cyclic AMP. 
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Fig.2. Inhibition by histamine antagonists of 
intracellular cyclic AMP concentration elevated by 
histamine in RPE cells. RPE cells from 9-day old 
embryos grown for 3 weeks in culture were reacted with 
1 x 10m6 M histamine in the presence of increasing 
concentrations of cimetidine (o), diphenhydramine (A) 
and pyrilamine (m). Maximal (100%) activity was 
defined as the cyclic AMP level in the presence of 1 x 
10m6 M histamine alone and was 131.3 f 17.8 pmol/mg 
RPE protein (? f SEM; N = 3). Histamine-elevated 
cyclic AMP levels obtained in the presence of 
antagonists were expressed as percentages of the mean of 
the maximal activity. Each point represents the average 
value of 3 culture dishes and the bar represents the SEM. 
by cimetidine occurs at 1.5 x lo-” M. Assuming a 
competitive inhibition, the inhibition constant (Kr) 
of cimetidine can be calculated according to the 
equation [ 121: 
KI = ZCso/(l + S/K,) 
where Ka is the concentration of histamine (5.8 x 
10e6 M, from fig.1) required to give half-maximal 
elevation of intracellular cyclic AMP concentra- 
tion; ZCSO (1.5 x low8 M) is the cimetidine concen- 
tration which produces half-maximal inhibition of 
the histamine effect and S (1 x 10m6 M) is the 
histamine concentration used in the inhibition 
study. The KI of cimetidine so calculated is 1.3 x 
lo-’ M. The basal cyclic AMP concentration is not 
affected by the presence of these antagonists. 
4. DISCUSSION 
Our study shows that cultured chick embryonic 
RPE is responsive to histamine. The effect is very 
significant in that a 40-fold stimulation of in- 
tracellular cyclic AMP production can be observed 
with 100 pM histamine within 3 min of addition of 
the agonist (fig. 1). Elevation of intracellular cyclic 
AMP by histamine shows a half-maximal activity 
(&) of 5.8 x 10T6 M. This Ka value is similar to 
that observed in the histamine-stimulated 
adenylate cyclase in a capillary-rich fraction from 
brain [ 131, and in guinea pig brain homogenate 
[14-161. In the presence of 3 x 10m6 M cimetidine, 
the histamine effect in elevating the RPE in- 
tracellular cyclic AMP concentration is completely 
abolished. Therefore it appears that cimetidine is a 
more potent inhibitor in RPE than in the capillary- 
rich fraction from brain, in which even in the 
presence of 5 x 10e6 M cimetidine, a half-maximal 
activity of 4 x 10m5 M of histamine in stimulation 
of adenylate cyclase was observed [13]. The 
histamine effect is mediated through an Hz-type of 
receptor, since neither of the Hi-antagonists 
(pyrilamine and diphenhydramine) show any effect 
on the histamine-elevated intracellular cyclic AMP 
concentration, while the Hz antagonist, cimetidine, 
effectively inhibits the histamine effect in a dose- 
dependent manner (fig.2) with an inhibition cons- 
tant (KI) of 1.3 x lo-* M. Cimetidine is thus about 
60 times more potent in the present system than in 
the inhibition of histamine-stimulated adenylate 
cyclase in the capillary-rich fraction from brain (KI 
= 7.5 x lo-’ M) [13]. 
The physiological function of HZ receptors in the 
RPE and the sources of the histamine input in vivo 
are not known at the present time. Nevertheless, 
the chick embryonic RPE appears to be the only 
homogeneous cell type that can be studied in 
culture to ultimately determine the nature of 
coupling between histamine receptors and 
adenylate cyclase. 
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